IDH1 and IDH2 Driven Intrahepatic Cholangiocarcinoma (IHCC): A comprehensive genomic and immune profiling study.

被引：8
|
作者：
Makawita, Shalini
Borad, Mitesh J.
Carapeto, Fernando
Kwong, Lawrence
Bekaii-Saab, Tanios S.
Murugesan, Karthikeyan
Ross, Jeffrey S.
Danziger, Natalie
Israel, Mason A.
McGregor, Kimberly
Janku, Filip
Javle, Milind M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA
[4] Fdn Med Inc, Cambridge, MA USA
[5] Fdn Med, Cambridge, MA USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4009
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Isocitrate dehydrogenase 1 (IDH1) driven Intrahepatic Cholangiocarcinoma (IHCC): A Comprehensive Genomic Profiling (CGP) Study
    Hemmerich, Amanda
    Killian, J. Keith
    Lechpammer, Mirna
    Lin, Douglas
    Danziger, Natalie
    Huang, Richard
    Decker, Brennan
    Janovitz, Tyler
    Mata, Douglas
    Elvin, Julia
    Ramkissoon, Shakti
    McGregor, Kimberly
    Ross, Jeffrey
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 970 - 971
  • [2] Isocitrate dehydrogenase 1 (IDH1) driven Intrahepatic Cholangiocarcinoma (IHCC): A Comprehensive Genomic Profiling (CGP) Study
    Hemmerich, Amanda
    Killian, J. Keith
    Lechpammer, Mirna
    Lin, Douglas
    Danziger, Natalie
    Huang, Richard
    Decker, Brennan
    Janovitz, Tyler
    Mata, Douglas
    Elvin, Julia
    Ramkissoon, Shakti
    McGregor, Kimberly
    Ross, Jeffrey
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 970 - 971
  • [3] IDH1 and IDH2 Mutations in Gliomas, AML, and Intrahepatic Cholangiocarcinoma
    Wachsmann, M. B.
    Hatanpaa, J.
    Chen, W.
    Hammer, S.
    Ram, R.
    Oliver, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1031 - 1032
  • [4] Differential IDH1 and IDH2 mutation-related landscape in intrahepatic cholangiocarcinoma
    Xu, Shuaishuai
    Qu, Wenxin
    Shen, Yifei
    Ruan, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] IDH1 and IDH2 Mutations Detected by Pyrosequencing in Cholangiocarcinoma
    Voss, J. S.
    Kerr, S. E.
    Fritcher, E. G. Barr
    Highsmith, W. E.
    Zhang, J.
    Roberts, L. R.
    Gores, G. J.
    Halling, K. C.
    Kipp, B. R.
    MODERN PATHOLOGY, 2012, 25 : 184A - 184A
  • [6] IDH1 and IDH2 Mutations Detected by Pyrosequencing in Cholangiocarcinoma
    Voss, J. S.
    Kerr, S. E.
    Fritcher, E. G. Barr
    Highsmith, W. E.
    Zhang, J.
    Roberts, L. R.
    Gores, G. J.
    Halling, K. C.
    Kipp, B. R.
    LABORATORY INVESTIGATION, 2012, 92 : 184A - 184A
  • [7] The genomic landscape of IDH1 mutant intrahepatic cholangiocarcinoma: a multicentre comprehensive analysis
    Rimini, Margherita
    Macarulla, Teresa Mercade
    Burgio, Valentina
    Lonardi, Sara
    Niger, Monica
    Scartozzi, Mario
    Raposelli, Ilario
    Aprile, Giuseppe
    Ratti, Francesca
    Pedica, Federica
    Verdaguer, Helena
    Nappo, Floriana
    Nichetti, Federico
    Lai, Eleonora
    Valgiusti, Martina
    Cappetta, Alessandro
    Fabregat, Carles
    Fassan, Matteo
    De Braud, Filippo
    Puzzoni, Marco
    Frassineti, Giovanni Luca
    Simionato, Francesca
    De Cobelli, Francesco
    Aldrighetti, Luca
    Fornaro, Lorenzo
    Cascinu, Stefano
    Gardini, Andrea Casadei
    JOURNAL OF HEPATOLOGY, 2022, 77 : S748 - S748
  • [8] IDH1 and IDH2 Mutations in Chondrosarcomas
    Nafa, K.
    Agaram, N. P.
    Borsu, L.
    Schwartz, G.
    Healey, J.
    Ladanyi, M.
    Hameed, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 700 - 700
  • [9] IDH1 and IDH2 Mutations in Gliomas
    Adam L. Cohen
    Sheri L. Holmen
    Howard Colman
    Current Neurology and Neuroscience Reports, 2013, 13
  • [10] Inhibitors of mutant IDH1 and IDH2
    Pamela Feliciano
    Nature Genetics, 2013, 45 (5) : 477 - 477
12345